SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0000950116-05-000234
Filing Date
2005-01-21
Accepted
2005-01-21 17:09:30
Documents
4

Document Format Files

Seq Description Document Type Size
1 S-3/A s3a.txt S-3/A 65057
2 EXHIBIT 23.1.1 ex23-1_1.txt EX-23 826
3 EXHIBIT 23.1.2 ex23-1_2.txt EX-23 777
4 EXHIBIT 23.1.3 ex23-1_3.txt EX-23 2868
  Complete submission text file 0000950116-05-000234.txt   71375
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-121456 | Film No.: 05542279
SIC: 2834 Pharmaceutical Preparations